[ad_1]
A nurse practitioner fills a syringe with the Pfizer COVID-19 vaccine on the Beaumont Well being workplaces in Southfield, Mich., on Nov. 5.
Jeff Kowalsky/AFP through Getty Pictures
conceal caption
toggle caption
Jeff Kowalsky/AFP through Getty Pictures
A nurse practitioner fills a syringe with the Pfizer COVID-19 vaccine on the Beaumont Well being workplaces in Southfield, Mich., on Nov. 5.
Jeff Kowalsky/AFP through Getty Pictures
The Meals and Drug Administration has approved the usage of a Pfizer-BioNTech booster in adolescents 12 to fifteen years outdated.
The company on Monday additionally shortened the time between the completion of main vaccination of the Pfizer-BioNTech COVID-19 vaccine and a booster dose to 5 months from six.
Lastly, the FDA allowed for a 3rd dose of vaccine in immunocompromised kids 5 to 11 years of age.
The director of the Facilities for Illness Management and Prevention, Rochelle Walensky, should nonetheless weigh in with a suggestion on the FDA’s announcement earlier than the adjustments can take impact.
“All through the pandemic, because the virus that causes COVID-19 has constantly developed, the necessity for the FDA to rapidly adapt has meant utilizing one of the best out there science to make knowledgeable choices with the well being and security of the American public in thoughts,” appearing FDA Commissioner Janet Woodcock, M.D., stated in a press release.
Woodcock stated it’s crucial for the general public to take “efficient, life-saving preventative measures,” together with booster photographs, throughout the present surge of infections pushed by the omicron variant.
The FDA stated it reached its determination after reviewing knowledge from Israel, which included info on 6,300 individuals between the ages of 12-15 who obtained a booster shot at the least 5 months after their preliminary two-dose vaccination. The information confirmed no new circumstances of two potential unintended effects that had been noticed in some younger individuals who obtained the vaccine — myocarditis, an irritation of the center, and pericarditis, an inflamation of the saclike tissue surrounding the center.
The CDC authorized the Pfizer vaccine for kids 12-15 in Could and for children 5-11 in November. There’s nonetheless no vaccine authorized within the U.S. for kids beneath age 5.
[ad_2]